EUVIMEDDescubrir EUVIMED
Open access

Aberrant centrosome biogenesis disrupts nephron and collecting duct progenitor growth and fate resulting in fibrocystic kidney disease

Tao Cheng, Chidera Agwu, Kyuhwan Shim, Baolin Wang, Sanjay Jain iD, Moe R Mahjoub iD

Development · 2023-12-15 · 150 (24)

DOI: 10.1242/dev.201976 ↗

At a glance

Journal article in Development, published online on 2023-12-21. Written by Tao Cheng and 5 co-authors. Institution: Department of Medicine, Division of Nephrology, Washington University in St Louis, St. Louis, MO 63110, USA. Major MEDLINE topics: Kidney, Polycystic Kidney Diseases. Cited 7 times so far (Crossref); 92 references. The full text is freely available in PubMed Central. Funded by: NIDDK NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Mutations that disrupt centrosome biogenesis or function cause congenital kidney developmental defects and fibrocystic pathologies. Yet how centrosome dysfunction results in the kidney disease phenotypes remains unknown. Here, we examined the consequences of conditional knockout of the ciliopathy gene Cep120, essential for centrosome duplication, in the nephron and collecting duct progenitor niches of the mouse embryonic kidney. Cep120 loss led to reduced abundance of both cap mesenchyme and ureteric bud populations, due to a combination of delayed mitosis, increased apoptosis and premature differentiation of progenitor cells. These defects resulted in dysplastic kidneys at birth, which rapidly formed cysts, displayed increased interstitial fibrosis and decline in kidney function. RNA sequencing of embryonic and postnatal kidneys from Cep120-null mice identified changes in the pathways essential for development, fibrosis and cystogenesis. Our study defines the cellular and developmental defects caused by centrosome dysfunction during kidney morphogenesis and identifies new therapeutic targets for patients with renal centrosomopathies.

Subjects

MeSH terms (MEDLINE)

KidneyPolycystic Kidney DiseasesCentrosomeHumansCell Cycle ProteinsMiceNephronsMice, KnockoutAnimalsFibrosis

Author keywords

Cell fateCentrioleCentrosomeCiliaCystic kidney diseaseFibrosisMouse

Substances

Cep120 protein, mouseCell Cycle Proteins

Authors and institutions

  • Department of Medicine, Division of Nephrology, Washington University in St Louis, St. Louis, MO 63110, USA.
  • Department of Genetic Medicine, Weill Medical College of Cornell University, New York, NY 10065, USA.
  • Department of Cell Biology and Physiology, Washington University in St Louis, St. Louis, MO 63110, USA.

ORCID profiles: Sanjay Jain, Moe R Mahjoub

Funding

  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • National Institute of Diabetes and Digestive and Kidney Diseases

Cite

APA

Cheng, T., Agwu, C., Shim, K., Wang, B., Jain, S., & Mahjoub, M. R. (2023). Aberrant centrosome biogenesis disrupts nephron and collecting duct progenitor growth and fate resulting in fibrocystic kidney disease. Development, 150(24). https://doi.org/10.1242/dev.201976

Vancouver

Cheng T, Agwu C, Shim K, Wang B, Jain S, Mahjoub MR. Aberrant centrosome biogenesis disrupts nephron and collecting duct progenitor growth and fate resulting in fibrocystic kidney disease. Development. 2023;150(24). doi:10.1242/dev.201976

BibTeX
@article{Cheng2023,
  author = {Cheng, Tao and Agwu, Chidera and Shim, Kyuhwan and Wang, Baolin and Jain, Sanjay and Mahjoub, Moe R},
  title = {Aberrant centrosome biogenesis disrupts nephron and collecting duct progenitor growth and fate resulting in fibrocystic kidney disease},
  journal = {Development},
  year = {2023},
  volume = {150},
  number = {24},
  doi = {10.1242/dev.201976}
}
Start for free →